GT
SNV

Greenleaf Trust’s Synovus SNV Stock Holding History

Greenleaf Trust’s Portfolio SNV Stock Details SNV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,341
Closed -$317K – 851
2025
Q4 		$317K Buy
6,341
+128
+2% +$6.15K ﹤0.01% 636
2025
Q3 		$305K Buy
6,213
+29
+0.5% +$1.49K ﹤0.01% 632
2025
Q2 		$320K Sell
6,184
-241
-4% -$11.1K ﹤0.01% 613
2025
Q1 		$300K Buy
6,425
+318
+5% +$16.4K ﹤0.01% 645
2024
Q4 		$313K Sell
6,107
-38
-0.6% -$1.97K ﹤0.01% 639
2024
Q3 		$273K Buy
6,145
+41
+0.7% +$1.79K ﹤0.01% 693
2024
Q2 		$245K Buy
6,104
+55
+0.9% +$2.08K ﹤0.01% 680
2024
Q1 		$242K Buy
6,049
+21
+0.3% +$789 ﹤0.01% 681
2023
Q4 		$227K Buy
+6,028
New +$184K ﹤0.01% 684
2022
Q2 		– Sell
-4,534
Closed -$222K – 778
2022
Q1 		$222K Buy
4,534
+168
+4% +$8.51K ﹤0.01% 695
2021
Q4 		$209K Buy
+4,366
New +$207K ﹤0.01% 721

Other funds holding SNV

WBWA
William B. Walkup & Associates Columbia, South Carolina $167M AUM 20.75% 1-Year Est. Return

Greenleaf Trust's SNV Position: Q1 2026 in Review

Greenleaf Trust sold out of Synovus (SNV) in Q1 2026, closing a stake of 6,341 shares — an estimated $317K sold.

Greenleaf Trust first reported a position in SNV in Q4 2021 and held it in 11 quarters. The position peaked at $320K in Q2 2025. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.

  • Greenleaf Trust reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
  • Greenleaf Trust sold 6,341 Synovus shares in Q1 2026, an estimated $317K.
  • Greenleaf Trust first reported a position in Synovus in Q4 2021 and held it in 11 quarters.
  • Greenleaf Trust's Synovus position peaked at $320K in Q2 2025.
  • 1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.

Based on Greenleaf Trust's 13F filing for Q1 2026, filed 27 Apr 2026.